GELESIS HOLDINGS, INC.

Profile

Company Names

GELESIS HOLDINGS, INC.

Addresses

501 BOYLSTON STREET, SUITE 6102, BOSTON, MA 02116

Phone Numbers

617-456-4718

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$575,684.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-08-11 
$575,684.00 
$50,575,684.00 
$50,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
ABRAHAM 
EXECUTIVE OFFICER
SIENA CAPITAL PARTNERS I, L.P.   |  SIENA CAPITAL PARTNERS ACCREDITED, L.P.   |  SELECTA BIOSCIENCES INC   |  THOSE ANIMALS, INC.   |  GELESIS HOLDINGS, INC.
ALISON 
 
BAUERLEIN 
DIRECTOR
ACTIVE LIFE SCIENTIFIC, INC.   |  GELESIS HOLDINGS, INC.   |  BALANCE OPHTHALMICS, INC.
KATHRYN 
 
CAVANAUGH 
DIRECTOR
CAPSTAR VENTURES, L.P.   |  ETERNEVA, INC.   |  CAPSTAR SPV-E, LLC   |  CAPSTAR SPV-USA, LLC   |  UNDERSCORE USA, INC.   |  GELESIS HOLDINGS, INC.   |  CAPSTAR SPV-USA2, LLC
ELAINE 
 
CHIQUETTE 
EXECUTIVE OFFICER
GELESIS HOLDINGS, INC.
CLAYTON 
 
CHRISTOPHER 
DIRECTOR
SWEET LEAF TEA CO   |  RHYTHM SUPERFOODS LLC   |  DE SPIRITS LLC   |  AKIMBO FINANCIAL, INC.   |  PIADINA INC   |  ZILKS FOODS LLC   |  HUMAN ENTERPRISES, LLC   |  NULO, INC.   |  CAVU VENTURE PARTNERS I, LP   |  AUSTIN EASTCIDERS HOLDINGS, INC.   |  CAVU VENTURE PARTNERS KH, LLC   |  CAVU VENTURE PARTNERS I AIV, LP   |  CAVU VENTURE PARTNERS I BLOCKER, LLC   |  CAVU VENTURE PARTNERS OY I, LLC   |  CAVU VENTURE PARTNERS OY II, LLC   |  TYG INVESTORS LLC   |  AGN INVESTORS LLC   |  PIK INVESTORS LLC   |  CDF INVESTORS LLC   |  WATERLOO SPARKLING WATER CORP.   |  SPARKLING COCKTAIL CORP.   |  CAVU VENTURE PARTNERS VP, LLC   |  FYG INVESTORS, LLC   |  CAVU VENTURE PARTNERS CCRJ, LLC   |  CDF INVESTORS II LLC   |  GFR INVESTORS LLC   |  CJH HOLDINGS LLC   |  RGN INVESTORS LLC   |  HAH INVESTORS LLC   |  LYRICAL FOODS, INC.   |  GOOD CULTURE, LLC   |  REBBL, INC.   |  QUE ONDA BEVERAGE, INC.   |  GELESIS HOLDINGS, INC.   |  KITSCH ACCESS FRIENDS + FAMILY, LP   |  KITSCH ACCESS INSTITUTIONAL, LP   |  PC ACCESS 4, LP   |  BLOOM NU LLC   |  BM ACCESS I, LP   |  ASTO CONSUMER PARTNERS FUND LP
PAUL 
 
FONTEYNE 
DIRECTOR
DALCOR PHARMACEUTICALS US, LLC   |  ALLYX THERAPEUTICS, INC.   |  REVELAR BIOTHERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.   |  GELESIS HOLDINGS, INC.   |  APNIMED, INC.   |  TRITON THERAPEUTICS, INC.
RAJU 
 
KUCHERLAPATI 
DIRECTOR
AVEO PHARMACEUTICALS INC   |  METAMARK GENETICS, INC.   |  KEW GROUP INC.   |  RASIO THERAPEUTICS, INC.   |  GELESIS HOLDINGS, INC.   |  REGENIMO BIOSCIENCES, INC.
HARRY 
L. 
LEIDER 
EXECUTIVE OFFICER
GELESIS HOLDINGS, INC.
ELLIOT 
 
MALTZ 
EXECUTIVE OFFICER
GELESIS INC   |  GELESIS HOLDINGS, INC.   |  ORGENESIS INC.
DAVID 
 
PASS 
EXECUTIVE OFFICER
REAVES W H + CO INC   |  GELESIS HOLDINGS, INC.
DOMINIC 
 
PERKS 
DIRECTOR
QUORSO GLOBAL INC.   |  GELESIS HOLDINGS, INC.
ALESSANDRO 
 
SANNINO 
EXECUTIVE OFFICER
GELESIS HOLDINGS, INC.
JANE 
 
WILDMAN 
DIRECTOR
GELESIS HOLDINGS, INC.
YISHAI 
 
ZOHAR 
EXECUTIVE OFFICER, DIRECTOR
GELESIS INC   |  GELESIS HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-08-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-08-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#